Shandong Xinhua Pharmaceutical Company Limited Asset Resilience Ratio

Latest as of December 2016: 0.64%

Shandong Xinhua Pharmaceutical Company Limited asset resilience ratio. Shandong Xinhua Pharmaceutical Company Limited (XIN) has an Asset Resilience Ratio of 0.64% as of December 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See XIN defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€30.00 Million

≈ $35.07 Million USD Cash + Short-term Investments

Total Assets

€4.72 Billion

≈ $5.52 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shandong Xinhua Pharmaceutical Company Limited (2016–2016)

Asset resilience ratio of Shandong Xinhua Pharmaceutical Company Limited from 2016 to 2016. This chart shows how Shandong Xinhua Pharmaceutical Company Limited's Asset Resilience Ratio has changed over time. Read how much debt does Shandong Xinhua Pharmaceutical Company L carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shandong Xinhua Pharmaceutical Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shandong Xinhua Pharmaceutical Company L total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€30.00 Million	0.64%
Total Liquid Assets	€30.00 Million	0.64%

Asset Resilience Insights

Limited Liquidity: Shandong Xinhua Pharmaceutical Company Limited maintains only 0.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Xinhua Pharmaceutical Company Limited Industry Peers by Asset Resilience Ratio

Compare Shandong Xinhua Pharmaceutical Company Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Galderma Group N SW:GALD	Drug Manufacturers - Specialty & Generic	3.56%
Enzymatica publ AB ST:ENZY	Drug Manufacturers - Specialty & Generic	22.17%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Walvax BioTech SHE:300142	Drug Manufacturers - Specialty & Generic	2.20%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Shandong Xinhua Pharmaceutical Company Limited Asset Resilience Ratio by Year (2016–2016)

Shandong Xinhua Pharmaceutical Company Limited asset resilience ratio by year from 2016 to 2016. The table below shows the annual Asset Resilience Ratio data for Shandong Xinhua Pharmaceutical Company Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	0.64%	€30.00 Million ≈ $35.07 Million	€4.72 Billion ≈ $5.52 Billion	--

pp = percentage points

About Shandong Xinhua Pharmaceutical Company Limited

F:XIN Germany Drug Manufacturers - Specialty & Generic

Market Cap

$132.23 Million

€113.10 Million EUR

Market Cap Rank

#17964 Global

#1680 in Germany

Share Price

€0.58

Change (1 day)

-0.85%

52-Week Range

€0.57 - €0.80

All Time High

€0.97